May 14, 2021 by Chain Drug Review
B. Douglas Hoey is the chief executive officer at the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association issued the following statement on behalf of CEO B. Douglas Hoey reacting to the government’s response to litigation that would close a regulatory loophole allowing massive corporate middlemen to heap retroactive fees on local pharmacies: “The retroactive fees that PBMs charge increased by 45,000 percent between 2010
April 22, 2021 by Chain Drug Review
National Community Pharmacists Association’s 2021 Congressional Pharmacy Fly-In, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Hundreds of independent neighborhood pharmacists participated in the National Community Pharmacists Association’s 2021 Congressional Pharmacy Fly-In, which was held virtually April 19-21. The purpose of the event is to urge Congress to support a pro-pharmacy, pro-patient agenda, including advancing efforts to stop unfair pharmacy benefit managers practices such as retroactive clawbacks called direct
April 13, 2021 by Chain Drug Review
B. Douglas Hoey is the chief executive officer at the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — A new survey of independent pharmacists released by the National Community Pharmacists Association finds that almost half are not getting enough or any doses of the coronavirus vaccine to serve their patients. Forty-seven percent say they are serving populations with a significant minority population. Nearly 80 percent operate in places with fewer
April 6, 2021 by Chain Drug Review
NCPA, NCPA Innovation Center/CPESN Community Pharmacy Fellowship
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Enrollment is now underway for the NCPA Innovation Center/CPESN Community Pharmacy Fellowship, sponsored by Good Neighbor Pharmacy, and continues through July 31. The program, which will be in its second year, begins Sept. 1, 2021. “You don’t have to be a recent pharmacy graduate to learn the latest in innovative patient care,” said
March 17, 2021 by Chain Drug Review
NCPA, NCPA Innovation Center Excellence Awards for 2021
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Five community pharmacies have been named recipients of the NCPA Innovation Center Excellence Awards for 2021, sponsored by QS/1, the National Community Pharmacists Association announced today. This is the fourth year of the NICE Awards competition, which was created to recognize pharmacies for their efforts to enhance their value, promote their services,
March 9, 2021 by Chain Drug Review
B. Douglas Hoey is the chief executive officer at the National Community Pharmacists Association., COVID-19 vaccines in pharmacies, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — A new survey released today by the National Community Pharmacists Association shows a strong preference among Americans to receive the COVID-19 vaccines from a trusted health care provider, such as their local pharmacist or doctor. According to a survey of 1,390 adults conducted by Public Policy Polling from Feb. 26-27,nearly 4 in 10
February 11, 2021 by Chain Drug Review
Chris Cella, McKesson, McKesson RxOwnership, NCPA
Leading Headlines, Pharmacy, Retail News, Supplier News
IRVING, Texas — McKesson RxOwnership, a no-fee resource for independent pharmacies seeking financial and ownership transaction guidance, signed a new five-year commitment with the National Community Pharmacists Association (NCPA) to sponsor the Pharmacy Ownership Workshop series. This renewed agreement lengthens the total commitment to nearly 15 years of sponsorship. RxOwnership is a complete and confidential partner when
February 10, 2021 by Chain Drug Review
B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association, the country’s leading group representing small business independent pharmacy, is teaming up with multiple state pharmacy associations on a campaign to promote the value of pharmacies in ensuring patient access to reliable, affordable health care. The campaign will also be educating the public, patients, and policymakers on
January 26, 2021 by Chain Drug Review
ASCP, B. Douglas Hoey, Chad Worz, COVID-19 vaccines, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — With many states struggling to immunize senior citizens and other vulnerable populations against COVID-19, two leading pharmacy groups today called on the nation’s governors to enlist independent long-term care pharmacies that know their communities best and can swing into action quickly. “Independent long-term care pharmacists have the experience, specialized knowledge, and, most
January 22, 2021 by Chain Drug Review
B. Douglas Hoey, Biden-Harris administration, NCPA
Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association issued the following statement from CEO B. Douglas Hoey, pharmacist, MBA, after theNational Strategy for the COVID-19 Response and Pandemic Preparedness was released by the Biden administration: “Small business neighborhood pharmacy has been engaged in the fight against the coronavirus from the start, jumping to action and installing
January 14, 2021 by Chain Drug Review
Brian Caswell, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — State and local health officials could accelerate the sputtering COVID-19 vaccine rollout by working more closely with community pharmacists who care for millions of patients across the country, said the National Community Pharmacists Association today. “Based on what we’re seeing, the vaccine rollout is going better in states where community pharmacists are
December 10, 2020 by Chain Drug Review
Anderson, NACDS, NCPA, PCMA Supreme Court, Rutledge
Featured Articles, Leading Headlines
ARLINGTON, Va. – Pharmacy groups including the National Association of Chain Drug Stores Thursday hailed the Supreme Court’s unanimous decision in Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association. The decision upholds an Arkansas law that, according to NACDS’ amicus brief, “prevents [pharmacy benefit manager] PBM contracts from reimbursing pharmacies at low rates
December 7, 2020 by Chain Drug Review
Medicaid, NACDS, NCPA
December 7, 2020, News
ARLINGTON, Va. — In a show of solidarity, the National Association of Chain Drug Stores (NACDS), the Washington State Pharmacy Association (WSPA) and the National Community Pharmacists Association (NCPA) welcomed a recent court decision that confirmed the pharmacy reimbursement plan for the state of Washington violates Medicaid rules. The pharmacy groups are also urging the
November 24, 2020 by Chain Drug Review
NACDS, NCPA
Leading Headlines, Pharmacy
Olympia, Wash.— The National Association of Chain Drug Stores (NACDS), the Washington State Pharmacy Association (WSPA) and the National Community Pharmacists Association (NCPA) today urged the federal Centers for Medicare & Medicaid Services (CMS) to bring to an end Washington State’s flawed pharmacy reimbursement plan. The pharmacy groups welcomed an Administrative Law Judge’s decision that confirmed